Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools IDH-mutant glioma

IDH-mutant glioma

Programs, trials, and reported response and survival for IDH-mutant glioma.

Data as of 11.07.2026

All studies

Vorasidenib

Vorasidenib Phase 1

Servier · Phase n/r · Status n/r · Enrollment n/r

Registry id n/r

ArmReported safety
Vorasidenib, non-enhancing glioman/r

A count stays a count. This page does not turn a count into a percent.